Yanqi Zhiqing Biomedicine

Yanqi Zhiqing Biomedicine is a neuro-focused biotechnology company based in Beijing, China, founded by the prominent neurobiologist Professor Rao Yi. The company leverages a proprietary Chemical Connectomics platform to discover small molecule drugs that target specific neural circuits involved in behavior and sensation. Its primary research focus includes the development of novel treatments for chronic itch (pruritus) and sleep disorders by modulating receptors such as CysLT2R and GRPR. By integrating high-throughput behavioral screening with molecular pharmacology, Yanqi Zhiqing aims to translate fundamental neuroscience discoveries into first-in-class therapeutics. The company is part of a cluster of innovative startups emerging from the Yanqi Lake scientific hub and is backed by leading venture capital firms.